Target intelligence / Profile preview

West Nile virus 5' untranslated region (WNV 5' UTR)

Target
WNV 5' UTR
Molecular classification
Viral RNA, Untranslated region, Cis-acting replication element
01

Overview

The West Nile virus (WNV) 5' untranslated region (UTR) is a highly conserved segment of the viral genome that serves as a critical regulatory hub for both translation and replication. It contains essential structural elements, such as stem-loop A (SLA), which acts as a promoter for the viral RNA-dependent RNA polymerase (NS5), and sequences that facilitate the cyclization of the genome required for RNA synthesis. The translation start site within this region is the point where the host cell machinery begins synthesizing the viral polyprotein, making it a prime target for therapeutic intervention. By targeting this site with antisense agents like morpholino oligomers, researchers can sterically block ribosomal access, effectively silencing viral protein production. Because these RNA structures are highly conserved across different WNV strains, they represent a robust target for broad-spectrum antiviral development. Inhibiting the function of the 5' UTR not only prevents the formation of new viral particles but also disrupts the early stages of the viral life cycle within the host cell.

Other names
West Nile virus genomic RNA translation start siteWNV 5' non-coding regionWNV 5' NCRWest Nile virus stem-loop AWNV SLA
02

Mechanism of action

Antisense oligonucleotides or morpholinos bind to the 5' UTR or the translation start site (AUG) via complementary base pairing, sterically hindering the assembly of the ribosomal initiation complex and preventing the translation of the viral polyprotein. This inhibition of protein synthesis subsequently halts viral replication and assembly.

03

Biological functions

Viral translation initiationViral RNA replicationRNA cyclizationRNA-protein interactionGenome packaging
04

Disease associations

West Nile feverWest Nile encephalitisInfection
05

Safety considerations

Off-target binding to host mRNADelivery challenges to the central nervous systemPotential for viral resistance through RNA mutationsInnate immune activation by exogenous RNA/oligonucleotides
06

Interacting drugs

Phosphorodiamidate morpholino oligomers (PMOs)

2 more in the full profile.

07

Biomarkers

Viral load (WNV RNA levels)Cerebrospinal fluid IgM antibodiesSerum IgM antibodies

Beyond the preview

Go deeper on West Nile virus 5' untranslated region (WNV 5' UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on West Nile virus 5' untranslated region (WNV 5' UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call